Generic Tofacitinib (6.26.2026)
Jun 26, 202630mEp. 1509
Dr. Jack Cush reviews the news and journal articles from RheumNow.com. Updates on tofacitinib, CAR-T therapy and AI.
Hosted by Dr. Cush · 🇺🇸 US · EN · 999 episodes
Established thought leaders with verified media credentials.
Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com
Dr. Cush hosts Rheumnow Podcast, a health show with 999 episodes published.
Dr. Jack Cush reviews the news and journal articles from RheumNow.com. Updates on tofacitinib, CAR-T therapy and AI.
The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use
Dr. Jack Cush reviews the news, journal reports and best ways to review EULAR 2026.
Dr. Jack Cush reviews the news, journal articles and missed quiz question.
Dr. Jack Cush talks of birthdays, Quizes and journal articles this week on the podcast.
Dr. Jack Cush discusses his favorite journal articles from the past week on RheumNow.com.
Dr Jack Cush reviews the news and journal reports from last weekon rheumnow.com
Dr. Jack Cush lectures on giving a great presentation; based on 40 years of lecturing in Rheumatology.
The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use
Dr. Jack Cush follows the money and all the news that fits the Rheumatology Gab for this past week.
Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com.
Dr. Jack Cush reviews the news and journal reports from RheumNow.com this week - including his top four favorite subjects.
Dr. Jack Cush reviews the news and major articles from this week, including FDA safety warnings, reports from AAD, PsA trials.
Dr. Schwartzman and Dr. Ruderman discuss how PsA disease activity across GRAPPA domains may guide treatment decisions, sharing both the evidence for and their experience with a JAKi across domains. Sponsored by AbbVie Me
Dr. Jack Cush reviews the journal reports and news from RheumNow.com. This week we discuss moral distress, FM in PsA, Lyme Vax is back & hidden but tangible benefits of the MDHAQ.
This month: Multiple FDA regulatory decisions germane to dermatology, psoriasis and lupus; and Eosinophilic Fasciitis (EF) reminder and should you worry about fibromyalgia? Show Notes: 1. FDA Approves Icotrokinra for Pla
Dr. Jack Cush reviews the regulatory actions, news and journal reports from this past week on RheumNow.com
STEP: Obesity and Inflammation: Weight management in Rheumatology. Dr. Uzma Haque STEP: Mitigating Risk for Rheumatic Disease Patients Undergoing Orthopedic Surgery. Dr. Susan Goodman
STEP: Disease Modification in OA - Dr. Tuhina Neogi STEP: History of Gout - Dr. Robert Terkeltaub
Rheumatoid Arthritis Faculty Panel Q&A
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Rheumnow Podcast has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their health audience.
Rheumnow Podcast is hosted by Dr. Cush. The show is categorised under health (fitness) and has published 999 episodes.
Rheumnow Podcast has published 999 episodes.
Rheumnow Podcast regularly covers health, fitness, medicine. It sits in the health category, with a fitness focus.
Rheumnow Podcast is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Rheumnow Podcast hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Rheumnow Podcast average 27 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Rheumnow Podcast's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 5 days ago.